Company Filing History:
Years Active: 2015-2025
Title: Lars L H Christensen: Innovator in Alpha-Amylase Variants
Introduction
Lars L H Christensen is a notable inventor based in Alleroed, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of alpha-amylase variants. With a total of 9 patents to his name, Christensen's work has had a substantial impact on various applications in the industry.
Latest Patents
One of Christensen's latest patents focuses on alpha-amylase variants and the polynucleotides encoding them. This invention relates to the development of variants of a parent alpha-amylase, which are crucial for various industrial processes. The patent also covers the polynucleotides that encode these variants, as well as nucleic acid constructs, vectors, and host cells that incorporate these polynucleotides. Furthermore, the methods of using these variant enzymes are also detailed in his patent.
Career Highlights
Throughout his career, Lars L H Christensen has worked with prominent companies in the biotechnology sector, including Novozymes A/S and Novo Zymes North America, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to innovative solutions in enzyme technology.
Collaborations
Christensen has collaborated with several professionals in his field, including Carsten Schau Andersen and Randall Scott Deinhammer. These collaborations have further enhanced his research and development efforts, leading to advancements in enzyme applications.
Conclusion
Lars L H Christensen is a distinguished inventor whose work on alpha-amylase variants has paved the way for new innovations in biotechnology. His contributions continue to influence the industry and inspire future research.